SCHEMBL24264148

SCHEMBL24264148

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccc(-c5cccc6sc7ccccc7c56)cc34)nc(-c3cccc4sc5ccccc5c34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.35
LIMK1 P53667 1/20 0.34
BRDT Q58F21 1/20 0.33
MMP12 P39900 1/20 0.32
ALOX5 P09917 2/20 0.32
F9 P00740 1/20 0.32
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
CHEK2 O96017 1/20 0.31
MAPK1 P28482 2/20 0.31
KMT2A Q03164 1/20 0.31
HCRTR1 O43613 1/20 0.31
SLC9A1 P19634 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24216811 0.98 PRKDC (0.36) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL22240851 0.98 PRKDC (0.36) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL24264342 0.97 PRKDC (0.33) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL23822326 0.97 PRKDC (0.33) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL24264145 0.97 PRKDC (0.33) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL24264153 0.97 PRKDC (0.35) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL22760327 0.97 PRKDC (0.35) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL24264149 0.97 PRKDC (0.35) PRKDCLIMK1BRDTMMP12ALOX5
SCHEMBL24264256 0.96 PLA2G2A (0.35) PRKDCBRDTMMP12ALOX5F9
SCHEMBL24264114 0.96 PLA2G2A (0.35) PRKDCBRDTMMP12ALOX5F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-11-28 US disclosed
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220059778-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, TRPC1, CYP1A1 PRKDC 4335/4885LIMK1 331/4885BRDT 2574/4885
US-11832517-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, TRPC1, CYP1A1 PRKDC 4335/4885LIMK1 331/4885BRDT 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.